FibroBiologics (FibroBiologics) Accounts Payable & Accrued Expense : $2.81 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Accounts Payable & Accrued Expense?

FibroBiologics's quarterly accounts payable & accrued expense increased from Sep. 2023 ($0.96 Mil) to Dec. 2023 ($1.59 Mil) and increased from Dec. 2023 ($1.59 Mil) to Mar. 2024 ($2.81 Mil).

FibroBiologics's annual accounts payable & accrued expense increased from Dec. 2021 ($0.46 Mil) to Dec. 2022 ($0.76 Mil) and increased from Dec. 2022 ($0.76 Mil) to Dec. 2023 ($1.59 Mil).

FibroBiologics Accounts Payable & Accrued Expense Historical Data

The historical data trend for FibroBiologics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Accounts Payable & Accrued Expense Chart

FibroBiologics Annual Data

Trend

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

0.46

0.76

1.59

FibroBiologics Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial				-	0.60	0.96	1.59	2.81

FibroBiologics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

FibroBiologics (FibroBiologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

SG0:Germany

Address

455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598

Website

https://www.fibrobiologics.com

FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (FibroBiologics) Headlines

From GuruFocus

FibroBiologics Announces Three Japanese Patents on Fibroblast Technology

By PRNewswire • 02-12-2024

FibroBiologics Announces Three United States Patents for Fibroblast Technology

By PRNewswire • 02-12-2024